Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 34

1.

Fruit shape diversity in the Brassicaceae is generated by varying patterns of anisotropy.

Eldridge T, Łangowski Ł, Stacey N, Jantzen F, Moubayidin L, Sicard A, Southam P, Kennaway R, Lenhard M, Coen ES, Østergaard L.

Development. 2016 Sep 15;143(18):3394-406. doi: 10.1242/dev.135327.

2.

Presence versus absence of CYP734A50 underlies the style-length dimorphism in primroses.

Huu CN, Kappel C, Keller B, Sicard A, Takebayashi Y, Breuninger H, Nowak MD, Bäurle I, Himmelbach A, Burkart M, Ebbing-Lohaus T, Sakakibara H, Altschmied L, Conti E, Lenhard M.

Elife. 2016 Sep 6;5. pii: e17956. doi: 10.7554/eLife.17956.

3.

Genome-Wide Analysis of PAPS1-Dependent Polyadenylation Identifies Novel Roles for Functionally Specialized Poly(A) Polymerases in Arabidopsis thaliana.

Kappel C, Trost G, Czesnick H, Ramming A, Kolbe B, Vi SL, Bispo C, Becker JD, de Moor C, Lenhard M.

PLoS Genet. 2015 Aug 25;11(8):e1005474. doi: 10.1371/journal.pgen.1005474.

4.

Correction: The Tinkerbell (Tink) Mutation Identifies the Dual-Specificity MAPK Phosphatase INDOLE-3-BUTYRIC ACID-RESPONSE5 (IBR5) as a Novel Regulator of Organ Size in Arabidopsis.

Johnson KL, Ramm S, Kappel C, Ward S, Leyser O, Sakamoto T, Kurata T, Bevan MW, Lenhard M.

PLoS One. 2015 Aug 20;10(8):e0136482. doi: 10.1371/journal.pone.0136482. No abstract available.

5.

Divergent sorting of a balanced ancestral polymorphism underlies the establishment of gene-flow barriers in Capsella.

Sicard A, Kappel C, Josephs EB, Lee YW, Marona C, Stinchcombe JR, Wright SI, Lenhard M.

Nat Commun. 2015 Aug 13;6:7960. doi: 10.1038/ncomms8960.

6.

The Tinkerbell (Tink) Mutation Identifies the Dual-Specificity MAPK Phosphatase INDOLE-3-BUTYRIC ACID-RESPONSE5 (IBR5) as a Novel Regulator of Organ Size in Arabidopsis.

Johnson KL, Ramm S, Kappel C, Ward S, Leyser O, Sakamoto T, Kurata T, Bevan MW, Lenhard M.

PLoS One. 2015 Jul 6;10(7):e0131103. doi: 10.1371/journal.pone.0131103. Erratum in: PLoS One. 2015;10(8):e0136482.

7.

Prognostic value of HPV-mRNA in sentinel lymph nodes of cervical cancer patients with pN0-status.

Dürst M, Hoyer H, Altgassen C, Greinke C, Häfner N, Fishta A, Gajda M, Mahnert U, Hillemanns P, Dimpfl T, Lenhard M, Petry KU, Runnebaum IB, Schneider A.

Oncotarget. 2015 Sep 8;6(26):23015-25.

8.

The draft genome of Primula veris yields insights into the molecular basis of heterostyly.

Nowak MD, Russo G, Schlapbach R, Huu CN, Lenhard M, Conti E.

Genome Biol. 2015 Jan 24;16:12. doi: 10.1186/s13059-014-0567-z.

9.

Atkinesin-13A modulates cell-wall synthesis and cell expansion in Arabidopsis thaliana via the THESEUS1 pathway.

Fujikura U, Elsaesser L, Breuninger H, Sánchez-Rodríguez C, Ivakov A, Laux T, Findlay K, Persson S, Lenhard M.

PLoS Genet. 2014 Sep 18;10(9):e1004627. doi: 10.1371/journal.pgen.1004627.

10.

The G-protein-coupled estrogen receptor (GPER/GPR30) in ovarian granulosa cell tumors.

Heublein S, Mayr D, Friese K, Jarrin-Franco MC, Lenhard M, Mayerhofer A, Jeschke U.

Int J Mol Sci. 2014 Aug 27;15(9):15161-72. doi: 10.3390/ijms150915161.

11.

Immunosuppressive Glycodelin A is an independent marker for poor prognosis in endometrial cancer.

Lenhard M, Heublein S, Kunert-Keil C, Vrekoussis T, Lomba I, Ditsch N, Mayr D, Friese K, Jeschke U.

BMC Cancer. 2013 Dec 30;13:616. doi: 10.1186/1471-2407-13-616.

12.

Insulin therapy for the treatment of type 1 diabetes during pregnancy.

Lenhard MJ, Kinsley BT.

J Matern Fetal Neonatal Med. 2014 Aug;27(12):1270-5. doi: 10.3109/14767058.2013.864631. Review.

13.

KRAS, BRAF genotyping reveals genetic heterogeneity of ovarian borderline tumors and associated implants.

Heublein S, Grasse K, Hessel H, Burges A, Lenhard M, Engel J, Kirchner T, Jeschke U, Mayr D.

BMC Cancer. 2013 Oct 18;13:483. doi: 10.1186/1471-2407-13-483.

14.

The G-protein coupled estrogen receptor (GPER/GPR30) is a gonadotropin receptor dependent positive prognosticator in ovarian carcinoma patients.

Heublein S, Mayr D, Vrekoussis T, Friese K, Hofmann SS, Jeschke U, Lenhard M.

PLoS One. 2013 Aug 9;8(8):e71791. doi: 10.1371/journal.pone.0071791.

15.

Target specificity among canonical nuclear poly(A) polymerases in plants modulates organ growth and pathogen response.

Vi SL, Trost G, Lange P, Czesnick H, Rao N, Lieber D, Laux T, Gray WM, Manley JL, Groth D, Kappel C, Lenhard M.

Proc Natl Acad Sci U S A. 2013 Aug 20;110(34):13994-9. doi: 10.1073/pnas.1303967110.

16.

Her-2/neu expression is a negative prognosticator in ovarian cancer cases that do not express the follicle stimulating hormone receptor (FSHR).

Heublein S, Vrekoussis T, Mayr D, Friese K, Lenhard M, Jeschke U, Dian D.

J Ovarian Res. 2013 Jan 22;6(1):6. doi: 10.1186/1757-2215-6-6.

17.

Mucin-1 and its relation to grade, stage and survival in ovarian carcinoma patients.

Engelstaedter V, Heublein S, Schumacher AL, Lenhard M, Engelstaedter H, Andergassen U, Guenthner-Biller M, Kuhn C, Rack B, Kupka M, Mayr D, Jeschke U.

BMC Cancer. 2012 Dec 15;12:600. doi: 10.1186/1471-2407-12-600.

18.

Correlation of thyroid hormone, retinoid X, peroxisome proliferator-activated, vitamin D and oestrogen/progesterone receptors in breast carcinoma.

Ditsch N, Mayr D, Lenhard M, Strauss C, Vodermaier A, Gallwas J, Stoeckl D, Graeser M, Weissenbacher T, Friese K, Jeschke U.

Oncol Lett. 2012 Oct;4(4):665-671.

19.

Steroid hormone receptor expression in ovarian cancer: progesterone receptor B as prognostic marker for patient survival.

Lenhard M, Tereza L, Heublein S, Ditsch N, Himsl I, Mayr D, Friese K, Jeschke U.

BMC Cancer. 2012 Nov 24;12:553. doi: 10.1186/1471-2407-12-553.

20.

Glycodelin A is a prognostic marker to predict poor outcome in advanced stage ovarian cancer patients.

Scholz C, Heublein S, Lenhard M, Friese K, Mayr D, Jeschke U.

BMC Res Notes. 2012 Oct 5;5:551. doi: 10.1186/1756-0500-5-551.

Items per page

Supplemental Content

Loading ...
Support Center